31 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 25621797 | High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant. | 2015 Apr | 1 |
2 | 21042310 | TBI and melphalan followed by allogeneic hematopoietic SCT in children with advanced hematological malignancies. | 2011 Aug | 1 |
3 | 18999930 | Polyethylene glycol conjugates of methotrexate and melphalan: synthesis, radiolabeling and biologic studies. | 2008 Oct | 1 |
4 | 17176891 | [Cryotherapy is useful and safe in the prevention of oral mucositis after high-dose melphalan (L-PAM)]. | 2006 Nov | 1 |
5 | 14761920 | Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-alpha and melphalan for bulky in-transit melanoma metastases. | 2004 Feb | 1 |
6 | 12189530 | Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy. | 2002 Aug | 1 |
7 | 11878777 | Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line. | 2001 Nov | 1 |
8 | 10789721 | Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. | 2000 May | 2 |
9 | 11079271 | Allograft with unrelated donor accentuates the gastrointestinal toxicity associated with high-dose melphalan and total body irradiation preparative for bone marrow transplantation in children. | 2000 Nov | 1 |
10 | 9548610 | Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases? | 1998 Apr-May | 1 |
11 | 9670271 | Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases. | 1998 | 1 |
12 | 9679558 | L-S,R-buthionine sulfoximine: historical development and clinical issues. | 1998 Apr 24 | 2 |
13 | 9951688 | Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration. | 1998 Dec | 1 |
14 | 9329556 | Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease. | 1997 Jul-Aug | 1 |
15 | 9516845 | Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. | 1997 Oct | 2 |
16 | 7622292 | Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line. | 1995 Jul 17 | 1 |
17 | 8004757 | In vivo modulation of several anticancer agents by beta-carotene. | 1994 | 1 |
18 | 2208589 | DNA adenine adducts induced by nitrogen mustards and their role in transcription termination in vitro. | 1990 Oct | 1 |
19 | 2260990 | Enhancement of melphalan (L-PAM) toxicity by reductive metabolites of 1-methyl-2-nitroimidazole, a model nitroimidazole chemosensitizing agent. | 1990 Dec 15 | 1 |
20 | 3178239 | [Reduced cisplatin-uptake by cisplatin-resistant human ovarian cancer cells]. | 1988 Oct | 1 |
21 | 3182309 | Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma. | 1988 Oct | 1 |
22 | 3349564 | A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma. | 1988 | 1 |
23 | 3497748 | Differences in sensitivity to melphalan between con A-activated and nonactivated human T-cell subsets. | 1987 Oct | 1 |
24 | 6434498 | Chemopotentiation by CB 1954: the importance of postincubations and the possible involvement of poly(ADP-ribosylation). | 1984 Sep | 1 |
25 | 6541216 | Modification of alkylating agent cytotoxicity by cisplatin. | 1984 Sep | 1 |
26 | 6546359 | Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer. | 1984 Feb 15 | 1 |
27 | 6882665 | Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole. | 1983 Aug | 1 |
28 | 7000345 | L-phenylalanine mustard (L-PAM): the first 25 years. | 1980 Apr-May | 1 |
29 | 536450 | Application of a simple high-performance liquid chromatographic method for the determination of melphalan in the presence of its hydrolysis products. | 1979 Sep 14 | 1 |
30 | 101843 | Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. | 1978 Dec 7 | 1 |
31 | 1016968 | Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. | 1976 Sep | 1 |